Best of 2017: Element Minnetonka significantly expands testing capabilities

With an additional seven test methods, Element expands its scope in implant testing capacity

December 29, 2017
Edited by Michelle Jacobson
Testing News

London, United Kingdom – Element Materials Technology’s Minnetonka laboratory, formerly Medical Device Testing (MDT), expanded its A2LA ISO 17025 scope by adding an additional seven test methods to its capabilities.

The new expanded scope will add up to 12 test frames to Element’s global leading implant testing capacity, resulting in decreased time to market for clients and improved quality of life for the patient. The test methods address product evaluation testing of hip, knee, spine, and trauma implants. These certifications add to the laboratory’s list of cardiovascular test methods.

‘’We are delighted to add these services to our facility in Minnetonka and further expand our capacity to support our clients,” says Rick Sluiters, EVP Aerospace, Element. “The Minneapolis area is a growth hub for medical devices and Minnetonka’s proximity will supplement our leading medical capabilities in the area including medical packaging, environmental, and EMC testing.

Element Minnetonka is the largest cardiovascular, A2LA accredited, testing facility operating in the U.S., with over $6 million invested in commercial fatigue and durability test systems, inspection instruments, and test fixturing inventory. The laboratory specializes in pulsatile, axial, and bending fatigue on stents, catheters, and heart valves, as well as neurostimulation devices.

quality medical